CA
NZ
UK
AU
IND
US
The bipartisan National Commission on Local Public Health Leadership introduced a comprehensive plan on July 27 designed to reinforce municipal health agencies and the officials who oversee them. The strategy calls for five coordinated steps that prioritize localized data networks and steady supplies of …
Neumora Therapeutics (NASDAQ: NMRA) disclosed clean repeat‑dose toxicology findings for its brain‑penetrant NLRP3 inhibitor NMRA‑215, a program targeting obesity and related cardiometabolic conditions. The company wrapped up a follow‑up toxicology program in rodents after earlier investigations raised audit considerations. Across the study, no unforeseen …
Precision BioSciences Inc (NASDAQ: DTIL) has announced significant changes to its executive leadership team, appointing Alex Kelly as Chief Operating Officer and Naresh Tanna as Chief Financial Officer. Mr. Kelly's compensation includes an annual base salary of $510,000, along with a target annual bonus …
Service Coordination, Inc. has taken a significant step in its leadership structure by appointing Amy Floria as its new Chief Financial Officer as of July 27, 2026. Floria, who has more than three decades of experience in finance, healthcare operations, quality assurance, and strategic …
AstraZeneca (OTC: AZNCF) posted earnings per share of $2.63 for the quarter, exceeding the consensus estimate of $2.55. Core earnings grew 18% year‑over‑year, and revenue remained in line with expectations for the year, prompting a positive response in market valuation. This performance showcases the …
Co-Diagnostics, Inc. (NASDAQ: CODX) has revised its equity distribution agreement with Maxim Group LLC, eliminating the previously set aggregate offering price limitation. The amendment lifts the earlier constraint that capped the total offering at $10 million, thereby granting the company expanded latitude to raise …
The voucher originated from a prior regulatory milestone when the FDA granted a priority review entitlement following approval of a therapy for a genetic disorder. This cash infusion arrives at a time when the company seeks to extend its runway for pipeline advancement and …
Freenome announced that its SimpleScreen™ CRC test has earned FDA clearance. This blood‑based assay is intended for adults at average risk of colorectal cancer, offering an alternative to traditional stool‑based methods. With an estimated 60 million people in the United States who have not …
Executives at USANA Health Sciences exercised stock options, indicating potential shifts in company strategy. This activity could signal confidence in the firm's future performance, which may influence investor sentiment.Key HighlightsExecutives at USANA Health Sciences exercised stock options on July 27.This action might suggest a …
Kymera Therapeutics, Inc. (NASDAQ: KYMR) has announced a significant leadership change with the appointment of Terence Rooney as the new Chief Medical Officer (CMO). This transition comes as Jared Gollob, MD, prepares to retire after more than eight years of steering the company’s clinical …
Please wait processing your request...